Raaj Medisafe India Ltd
Raaj Medisafe India Ltd (RAAJMEDI) last reported results for the quarter ended Jun 2026, with sales of ₹29.46 crore and net profit of ₹1.97 crore. The stock last traded at ₹103, a market capitalisation of ₹169 crore, on a P/E of 71.6. Over the past 52 weeks the stock has ranged between ₹64.1 and ₹104. Figures are as of 6 Oct 2026 and are not real time.
Raaj Medisafe India Ltd share price and key metrics
- Current price
- ₹103
- Market cap
- ₹169 cr
- Stock P/E
- 71.6
- Book value
- ₹28.5
- ROE
- 4.91%
- ROCE
- 11.9%
- Dividend yield
- 0.00%
- 52w high / low
- 104/64.1
Metrics as of 6 Oct 2026. Not real time.
Track Raaj Medisafe India Ltd
Cruxal reads every Raaj Medisafe India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Raaj Medisafe India Ltd growth and returns
- 10 Years
- 46%
- 5 Years
- 20%
- 3 Years
- 27%
- TTM
- 42%
- 10 Years
- 14%
- 5 Years
- -5%
- 3 Years
- -18%
- TTM
- -66%
- 10 Years
- 30%
- 5 Years
- 9%
- 3 Years
- 34%
- 1 Year
- 40%
- 10 Years
- %
- 5 Years
- 24%
- 3 Years
- 17%
- Last Year
- 5%
Raaj Medisafe India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹29.46 cr, up 86.1% from ₹15.83 cr a year earlier. Net profit was ₹1.97 cr, up 34.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 10.91 | 14.59 | 24.4 | 15.83 | 18.4 | 20.71 | 25.08 | 29.46 |
| Expenses | 9.18 | 12.37 | 21.29 | 13.21 | 15.65 | 17.02 | 22.37 | 25.4 |
| Operating profit | 1.73 | 2.22 | 3.11 | 2.62 | 2.75 | 3.69 | 2.71 | 4.06 |
| OPM % | 15.86% | 15.22% | 12.75% | 16.55% | 14.95% | 17.82% | 10.81% | 13.78% |
| Other income | 0 | -0.01 | 0.11 | 0.01 | 0.23 | 0.04 | 0.28 | 0.15 |
| Interest | 0.36 | 0.52 | 0.68 | 0.68 | 0.82 | 1.38 | 1.08 | 0.86 |
| Depreciation | 0.23 | 0.4 | 0.44 | 0.49 | 0.43 | 0.5 | 0.63 | 0.71 |
| Profit before tax | 1.14 | 1.29 | 2.1 | 1.46 | 1.73 | 1.85 | 1.28 | 2.64 |
| Tax % | 15.79% | 19.38% | -65.24% | 0.00% | 0.00% | -2.70% | 353.12% | 25.00% |
| Net profit | 0.97 | 1.03 | 3.48 | 1.46 | 1.73 | 1.89 | -3.23 | 1.97 |
| EPS (₹) | 0.73 | 0.78 | 2.63 | 1.11 | 1.32 | 1.44 | -1.97 | 1.20 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Raaj Medisafe India Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.42 | 4.62 | 4.8 | 21.8 | 31.8 | 34.68 | 38.61 | 43.24 | 62.42 | 79.97 | 93.65 |
| Operating profit | -0.08 | -0.45 | -0.78 | 1.51 | 4.06 | 5.08 | 5.61 | 6.64 | 8.63 | 11.76 | 13.21 |
| OPM % | -1.81% | -9.74% | -16.25% | 6.93% | 12.77% | 14.65% | 14.53% | 15.36% | 13.83% | 14.71% | 14.11% |
| Net profit | -0.83 | -1.43 | -1.59 | -0.29 | 2.3 | 3.01 | 3.33 | 3.33 | 6.13 | 1.81 | 2.36 |
| EPS (₹) | -1.65 | -2.84 | -3.15 | -0.58 | 2.10 | 2.75 | 3.04 | 3.04 | 4.64 | 1.10 | 1.99 |
TTM is the trailing twelve months to the most recent quarter.
Raaj Medisafe India Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 5.00 | 5.00 | 5.00 | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 | 13.18 | 16.42 |
| Reserves | -9.88 | -11.32 | -12.91 | -12.09 | -9.83 | -6.75 | -3.41 | -0.07 | 13.74 | 30.32 |
| Borrowings | 9.03 | 9.43 | 11.61 | 11.87 | 13.13 | 13.02 | 15.62 | 25.93 | 34.57 | 64.67 |
| Other liabilities | 1.62 | 2.07 | 1.42 | 2.91 | 2.41 | 2.45 | 2.66 | 4.52 | 7.49 | 9.94 |
| Total liabilities | 5.77 | 5.18 | 5.12 | 13.59 | 16.61 | 19.62 | 25.77 | 41.28 | 68.98 | 121.35 |
| Fixed assets | 3.49 | 3.47 | 3.48 | 7.03 | 7.26 | 9.30 | 8.63 | 10.72 | 23.68 | 39.04 |
| CWIP | 0.54 | 0.00 | 0.00 | 0.00 | 1.60 | 0.00 | 1.59 | 10.14 | 8.51 | 26.76 |
| Investments | 0.01 | 0.01 | 0.01 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Other assets | 1.73 | 1.70 | 1.63 | 6.49 | 7.68 | 10.25 | 15.48 | 20.35 | 36.72 | 55.48 |
| Total assets | 5.77 | 5.18 | 5.12 | 13.59 | 16.61 | 19.62 | 25.77 | 41.28 | 68.98 | 121.35 |
As reported by the company. Total assets equal total liabilities by construction.
Raaj Medisafe India Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0.23 | -0.01 | -1.37 | -1.03 | 2.23 | 2.45 | 0.17 | 4.27 | -0.09 | 3.67 |
| Cash from investing | -0.68 | 0.27 | -0.05 | -0.21 | -2.78 | -0.96 | -1.67 | -13.00 | -16.42 | -34.95 |
| Cash from financing | 0.92 | -0.26 | 1.43 | 1.24 | 0.51 | -1.47 | 1.49 | 8.74 | 16.52 | 44.23 |
| Net cash flow | 0.01 | 0.00 | 0.00 | 0.00 | -0.04 | 0.02 | -0.01 | 0.02 | 0.02 | 12.95 |
| Free cash flow | -0.91 | 0.25 | -1.43 | -1.25 | -0.56 | 1.31 | -1.56 | -7.37 | -13.01 | -29.83 |
| CFO / operating profit | 288% | 2% | 176% | -68% | 55% | 48% | 14% | 74% | 10% | 31% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Raaj Medisafe India Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -9.06% | -20.94% | -32.01% | 16.41% | 27.09% | 27.99% | 24.23% | 19.58% | 15.02% | 11.89% |
| Debtor days | 35.51 | 60.83 | 62.35 | 78.69 | 56.24 | 57.25 | 64.76 | 66.60 | 97.65 | 53.63 |
| Inventory days | 141.13 | 98.61 | 64.61 | 20.96 | 24.65 | 48.18 | 89.79 | 105.50 | 67.86 | 105.98 |
| Days payable | 233.60 | 275.22 | 132.62 | 51.56 | 19.46 | 6.66 | 10.60 | 8.85 | 35.77 | 35.94 |
| Cash conversion cycle | -56.96 | -115.78 | -5.66 | 48.10 | 61.43 | 98.77 | 143.95 | 163.24 | 129.75 | 123.67 |
| Working capital days | -87.53 | -141.42 | -123.95 | -7.53 | 8.72 | 4.84 | 36.40 | 21.61 | 11.29 | 9.72 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Raaj Medisafe India Ltd shareholding pattern
Promoters held 59.08% at Jun 2026, down from 73.45% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.45% | 73.45% | 73.45% | 73.45% | 73.80% | 73.80% | 73.80% | 59.08% |
| Public | 26.55% | 26.56% | 26.55% | 26.55% | 26.20% | 26.20% | 26.19% | 40.92% |
| No. of shareholders | 8,181 | 8,151 | 8,138 | 8,141 | 7,810 | 7,781 | 7,770 | 7,783 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Raaj Medisafe India Ltd corporate filings
- Raaj Medisafe India Limited Announces Results of 41st Annual General Meeting and Approval of Material Related Party TransactionsAGM/EGMlow impact
Cruxal's analysis: Raaj Medisafe India Limited has successfully concluded its 41st Annual General Meeting…
Read the full analysis - Raaj Medisafe India Limited concludes 41st Annual General Meeting; shareholders approve routine business and related party transactionsAGM/EGMlow impact
Cruxal's analysis: Raaj Medisafe India Limited has successfully concluded its 41st Annual General Meeting…
Read the full analysis - Raaj Medisafe India Limited concludes 41st Annual General Meeting; approves related party transactionsAGM/EGMlow impact
Cruxal's analysis: Raaj Medisafe India Limited has successfully concluded its 41st Annual General Meeting…
Read the full analysis - Trading window of the Company will remained closed for dealing in Company''s shares for Promoters/Directors/designated employees/officers and their immediate relatives from 01.10.2026 till ....Insider Trading / SASTlow impact
- Raaj Medisafe India Limited: Promoter executes inter-se transfer of 26,993 shares via giftInsider Trading / SASTlow impact
Cruxal's analysis: Raaj Medisafe India Limited has disclosed an off-market inter-se transfer of 26,993…
Read the full analysis - Raaj Medisafe India Limited: Promoter executes inter-se transfer of 1.94 lakh shares via giftInsider Trading / SASTlow impact
Cruxal's analysis: Raaj Medisafe India Limited has disclosed an off-market inter-se transfer of 1,94,700…
Read the full analysis - Raaj Medisafe India Limited: Promoter Group Executes Inter-se Transfer of Shares via GiftInsider Trading / SASTlow impact
Cruxal's analysis: Raaj Medisafe India Limited has disclosed an off-market inter-se transfer of 2 lakh 21…
Read the full analysis - Raaj Medisafe India Limited secures a 17.02 crore government order for baby diaper supplyCompany Updatehigh impact
Cruxal's analysis: Raaj Medisafe India Limited has received a Letter of Award from the Madhya Pradesh Public…
Read the full analysis - Raaj Medisafe India Limited Announces 41st Annual General Meeting and Book Closure DatesCorp. Actionlow impact
Cruxal's analysis: Raaj Medisafe India Limited has scheduled its 41st Annual General Meeting for September…
Read the full analysis - Raaj Medisafe India Limited Announces 41st AGM and Seeks Shareholder Approval for Material Related Party TransactionsAGM/EGMmedium impact
Cruxal's analysis: Raaj Medisafe India Limited has scheduled its 41st Annual General Meeting for September…
Read the full analysis - Raaj Medisafe India Ltd submits compliance filing regarding shareholder communication under Regulation 36(1)(b)Company Updatelow impact
Cruxal's analysis: The company has submitted copies of letters sent to shareholders whose e-mail addresses…
Read the full analysis - Raaj Medisafe India Ltd submits Annual Report for the financial year 2026Otherslow impact
Cruxal's analysis: Raaj Medisafe India Ltd has filed its Annual Report for the financial year 2026 in…
Read the full analysis - Raaj Medisafe India Limited Reports Q1 FY27 Financial Results with Significant Revenue and Profit GrowthCompany Updatehigh impact
Cruxal's analysis: Raaj Medisafe India Limited has released its unaudited financial results for the quarter…
Read the full analysis - Raaj Medisafe India Reports Strong Q1 FY27 Performance with 86% YoY Revenue Growth and Significant Profit TurnaroundResulthigh impact
Cruxal's analysis: Raaj Medisafe India Limited reported robust financial results for the quarter ended June…
Read the full analysis - Raaj Medisafe India Limited confirms nil deviation in utilization of 18.01 crore raised via preferential issueCompany Updatelow impact
Cruxal's analysis: Raaj Medisafe India Limited has filed its statement of deviation or variation for the…
Read the full analysis - Raaj Medisafe India Limited appoints Mr. Vipul Parakh as Chief Financial OfficerCompany Updatelow impact
Cruxal's analysis: Raaj Medisafe India Limited has announced the appointment of Mr. Vipul Parakh as the new…
Read the full analysis - Raaj Medisafe India Limited Announces CFO Transition and Schedules 41st Annual General MeetingBoard Meetinglow impact
Cruxal's analysis: Raaj Medisafe India Limited has announced a leadership change with the resignation of Ms…
Read the full analysis - Raaj Medisafe India to Announce Q1 FY27 Results, Appoint CFO, and Review Preferential Allotment Fund Utilization on August 12Board Meetinghigh impact
Cruxal's analysis: Raaj Medisafe India Limited has scheduled a Board Meeting for August 12, 2026, to…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.